|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732 INR | -0.95% |
|
-0.05% | +34.12% |
| 25/06 | Jubilant Pharmova Arm Completes Prepayment of $75 Million Term Loan | MT |
| 18/06 | Jubilant Pharmova Gets 15 Observations from US FDA for Unit's Manufacturing Facility in Canada; Shares Dip 3% | MT |
Jubilant Pharmova Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 17,464 million compared to INR 16,609 million a year ago. Revenue was INR 17,730 million compared to INR 16,824 million a year ago.
Net loss was INR 586 million compared to INR 979 million a year ago. Basic loss per share from continuing operations was INR 3.69 compared to INR 6.15 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +34.12% | 141.02Cr | |
| +55.32% | 82TCr | |
| +44.05% | 64TCr | |
| -6.75% | 35TCr | |
| +13.56% | 31TCr | |
| +10.68% | 30TCr | |
| +16.57% | 24TCr | |
| +2.04% | 22TCr | |
| +13.31% | 22TCr | |
| +8.48% | 17TCr |
JUBILANT PHARMOVA LIMITED 
